Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Post by antigua1987on Apr 21, 2021 6:12pm

Small presentation request -

Congrats Fred, we appreciate your presentations; however, could you reduce your cursor movement upon page landing. Slightly distracting even though most here know what your about to say.  ...more  
313
Comment by qwerty22on Apr 16, 2021 2:32pm

RE:Pfizer to require boosters every year

So the theory of where blood clot issue comes from is it's to do with the adenovirus part of the vaccine, that's why it appears in j&j and AZ. Moderna and Biontech are mRNA vaccines are ...more  
307
Discussion
Post by cribbonson Apr 15, 2021 3:19pm

Pfizer to require boosters every year

Hopefully, IMV`s vaccine will last better than the rest.
163
Discussion
Post by LR6852on Apr 12, 2021 12:44pm

Industry Pressure on Cdn Government

See link below: https://mms.businesswire.com/media/20210412005231/en/870479/5/4980365_Letter_from_LSO_to_PM_Trudeau_April_12_2021.jpg?download=1
246
Comment by qwerty22on Apr 07, 2021 2:44pm

RE:RE:RE:RE:RE:Hmm. So, collaboration continues?

Accelerated approval is (almost) always the case in cancer in these types of studies because it depends on surrogate endpoints, you shouldn't think this is some sort of special achievement by IMV. ...more  
345
Discussion
Comment by Biotech010on Apr 07, 2021 2:26pm

RE:RE:RE:RE:Hmm. So, collaboration continues?

the trial is designed to get the accelarated approval. They need to repeat in a larger number of patients the data that they had in the PDL-1 positive patient population.  That is want ...more  
299
Discussion
Comment by alexmed95on Apr 07, 2021 1:37pm

RE:Sold

Smart man, I have around the same number of shares now only because my BE price is higher. When it reach BE (if it reach), I will sold out. 
190
Discussion
Post by Hideawayon Apr 07, 2021 1:30pm

Sold

Not that it matters to others, but I've had it with IMVand sold all my shares except for 1000. Hard to pull the trigger but I feel like we've been manipulated by this Company with details so ...more  
323
Discussion
Comment by qwerty22on Apr 07, 2021 11:14am

RE:RE:RE:Hmm. So, collaboration continues?

So they aren't even just focusing on PD-L1 positive patients at this point. It really is just a continuation of Spirel with a few extra arms to clarify the role of the components of the combo.
227
Discussion
Comment by qwerty22on Apr 07, 2021 10:59am

RE:RE:Hmm. So, collaboration continues?

I want to better understand the nuances of the trial design, do you have any thoughts? I took a quick look at what Simon's two stage design means. It seems it's typically seen as a Ph2a trial, ...more  
172
Discussion
Post by europe10on Apr 07, 2021 10:55am

No money

No money in s deal is the IMV route. They do not want to "give away" a lot of the product, and also to be able to test/work with other partners. Risk is that they instead are forced to give ...more  
249
Comment by Breakthoroughon Apr 07, 2021 10:47am

RE:RE:RE:Hmm. So, collaboration continues?

True. Anyway, in relation to Cyclophosphamyde they have to already know something, because of the comparison between the two ovarian cohorts in the Basket Trial. But they didn't eisclose data...
145
Discussion
Comment by Hideawayon Apr 07, 2021 10:36am

RE:RE:Public Relations

Very discouraging news release. They do not even have the decency to elaborate on the funding situation. Losing a great deal of respect for this Company. Fully expect we will have a down day as few ...more  
167
Discussion
Comment by qwerty22on Apr 07, 2021 10:30am

RE:Public Relations

What this announcement does for me is really place the pre-existing data in the right context as a post-hoc analysis. What the company signalled might happen, and what would really have been ...more  
169
Discussion
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities